Latest 20-F annual reports

Novartis AG's recent filing details amendments to its Articles of Incorporation and provides insights into its corporate governance structure.

Novo Nordisk's 2023 annual report highlights significant sales growth driven by diabetes and obesity care, while addressing supply challenges and expanding its pipeline through strategic acquisitions and R&D investments.

Ostin Technology Group files its annual report on Form 20-F and details an employment agreement with its Chief Financial Officer, Qiaoyun Xie.

Globavend Holdings Limited's fiscal year 2023 saw a decrease in revenue, despite an increase in gross profit, as the company navigated strategic shifts and economic factors.

Universe Pharmaceuticals INC obtains a $1.37 million working capital loan from Bank of Beijing Co., Ltd. to support its business operations.

Clearmind Medicine Inc. releases its 20-F filing, outlining financial results, business overview, and an executive officer clawback policy.

Farmmi, Inc. formalizes employment terms with Deheng Zhang as Chief Operating Officer, effective April 1, 2023.

EZGO Technologies Ltd. files its annual report on Form 20-F, detailing financial results for the fiscal year ended September 30, 2023, and outlining key aspects of its corporate structure, risk factors, and governance policies.

Aluminum Corporation of China Limited files an amendment to its 2022 annual report on Form 20-F to address specific comments received from the SEC regarding foreign jurisdictions and exhibits.

KWESST Micro Systems Inc. has filed amended employment contracts for key executives and updated corporate governance policies, including an incentive compensation recovery policy.

Birkenstock Holding PLC finalizes a Tax Receivable Agreement (TRA) with BK LC Lux MidCo S. r.l. concerning pre-IPO tax assets and their impact on future tax liabilities.

JX Luxventure Limited files an amendment to its 20-F to address additional SEC comments regarding its original report for the fiscal year ended December 31, 2022.

Bionomics Limited has filed an amendment to its annual report on Form 20-F to include management's assessment of internal controls over financial reporting and certifications from the CEO and CFO.

Baijiayun Group Ltd files its annual report on Form 20-F, detailing its financial results and operations for the fiscal year ended June 30, 2023.

Waldencast PLC reports a complex financial year marked by an SEC investigation, restatement of financials, and strategic shifts in its global beauty and wellness operations.

JD.com files an amendment to its 2022 annual report to address SEC comments regarding disclosures on foreign jurisdictions and exhibits.